India Generic Injectables Market Research and Forecast Report 2023-2028

1. India Generic Injectables Market Research and Forecast Report 2023- 2028 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description India Generic Injectables Market Research Report 2023-2028: According to the latest report by IMARC Group, titled "India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the India generic injectables market size reached US$ 2.4 Billion in 2022. A generic injectable is a drug having the same pharmaceutical composition as its branded counterpart in safety, strength, dosage form, performance, quality, and route of administration. It is cost-effective as generic injectable does not have to undergo animal testing and clinical studies to demonstrate safety and effectiveness. As it also delivers the same amount of active ingredients to the body, the demand for generic injectables is rising across India. Request for a PDF sample of this report: https://www.imarcgroup.com/india-generic-injectables- market/requestsample

4. Report Description and Highlights Report Description India Generic Injectables Market Trends: The growing prevalence of chronic diseases, such as cancer, stroke, diabetes, septicemia, influenza and pneumonia, and respiratory and Alzheimer's disease, represents one of the key factors driving the market in India. Moreover, the Government of India is extensively investing in research and development (R&D) activities to support the introduction of innovative generic injectables and provide effective drug administration, thereby enabling faster recovery of patients. This, along with the expanding healthcare industry, is contributing to the growth of the market in the country. In addition, technological advancements in the drug delivery systems, such as the introduction of self-injection devices, are positively influencing the market. Besides this, the increasing number of health insurance companies in the country is offering lucrative growth opportunities to industry investors. Additionally, the rising awareness among the masses about the benefits of using generic injectables is propelling the growth of the market in India. Apart from this, there is a rise in the shortage of branded medicines and the expiry of patents of branded items in the country. This, coupled with the burgeoning life science industry, is catalyzing the demand for generic injectables. Furthermore, the introduction of 3D printing technology in the country that helps manufacture generic drugs with varying release dates and tastes is bolstering the growth of the market. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a CAGR of 12.4% during the forecast period (2023-2028). View Report TOC, Figures and Tables: https://www.imarcgroup.com/india-generic-injectables-market

5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Therapeutic Area: •Oncology •Anaesthesia •Anti-infectives •Parenteral Nutrition •Cardiovascular Breakup by Container: •Vials •Ampoules •Premix •Prefilled Syringes Breakup by Distribution Channel: •Hospitals •Retail Pharmacy

6. Report Description and Highlights Report Description Breakup by Region: •North India •West and Central India •South India •East India

7. Key Questions Answered in the Report Report Description 1. How has the India generic injectables market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the India generic injectables market? What are the key regional markets? What is the breakup of the market based on the therapeutic area? What is the breakup of the market based on the container? What is the breakup of the market based on the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the India generic injectables market and who are the key players? 10. What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.

8. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 India Generic Injectables Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

9. Report DescriptionTable of Contents 6 Market Breakup by Therapeutic Area 6.1 Oncology 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Anaesthesia 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Anti-infectives 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Parenteral Nutrition 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Cardiovascular 6.5.1 Market Trends 6.5.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/india-generic-injectables-market/toc

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com